SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kamuran Türker, Murat Albayrak, Berna Öksüzoğlu, Elçin Balc, Mustafa C. Oğan, Gülşen İskender, Fevzi Altuntaş, Entecavir as a first-line treatment for hepatitis B virus reactivation following polychemotherapy for chronic lymphocytic leukemia and invasive ductal carcinoma, European Journal of Gastroenterology & Hepatology, 2015, 27, 1, 39

    CrossRef

  2. 2
    Dan Li, Gao Gao, Hong Jiang, Zhenghao Tang, Yongsheng Yu, Guoqing Zang, Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients, European Journal of Gastroenterology & Hepatology, 2015, 27, 1, 65

    CrossRef

  3. 3
    Hong Li, Hong-min Zhang, Li-fen Chen, Ya-qin Chen, Ling Chen, Hong Ren, Huai-dong Hu, Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: A systematic review and meta-analysis, Clinics and Research in Hepatology and Gastroenterology, 2015, 39, 1, 80

    CrossRef

  4. 4
    Ya-Wen Yang, Chih-Yuan Lee, Rey-Heng Hu, Po-Huang Lee, Meng-Kun Tsai, Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients, Clinical and Experimental Nephrology, 2014, 18, 1, 144

    CrossRef

  5. 5
    Xiang-Yuan Wu, Xing Li, Zhan-Hong Chen, Jing-Yun Wen, Qu Lin, Yan-Fang Xing, Min Dong, Li Wei, Tian-Tian Wang, Jie Chen, Ze-Xiao Lin, Xiang-bo Wan, Dan-Yun Ruan, Xiao-Kun Ma, An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study, Tumor Biology, 2013, 34, 2, 909

    CrossRef

  6. 6
    Ding Li, Hong Cheng, Weidong Gong, Yinghao Jiang, Ping Liang, Ju Zhang, Detection of primary YMDD mutations in HBV-related hepatocellular carcinoma using hybridization-fluorescence polarization, Journal of Virological Methods, 2013, 187, 2, 259

    CrossRef

  7. 7
    Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca, Fausto Roila, Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis, Critical Reviews in Oncology/Hematology, 2013, 87, 1, 12

    CrossRef

  8. 8
    Yoshimi Ide, Yoshinori Ito, Shunji Takahashi, Nahomi Tokudome, Kokoro Kobayashi, Tsutomu Sugihara, Masaya Hattori, Masahiro Yokoyama, Akira Uchiyama, Kazuaki Inoue, Norio Sakurai, Kiyohiko Hatake, Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer, Breast Cancer, 2013, 20, 4, 367

    CrossRef

  9. 9
    Jeong Won Jang, Management of Patients with Hepatitis B Virus Infection Who Receive Immunosuppressive Treatment or Chemotherapy, Korean Journal of Medicine, 2012, 82, 2, 149

    CrossRef

  10. 10
    H.-R. Li, J.-J. Huang, H.-Q. Guo, X. Zhang, Y. Xie, H.-L. Zhu, L.-Z. Zhai, X.-X. Pu, Y. Huang, C.-C. Guo, T.-Y. Lin, Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy, Journal of Viral Hepatitis, 2011, 18, 12
  11. 11
    Jianguo Lu, Weidong Gong, Hong Cheng, Zhiqun Wu, Ding Li, Xiangling Wang, Ping Liang, Ju Zhang, Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients, Virology Journal, 2011, 8, 1, 362

    CrossRef

  12. 12
    Zeinab K Hassan, Mohamed M Hafez, Tarek M Mansor, Abdel Zekri, Occult HBV infection among Egyptian hepatocellular carcinoma patients, Virology Journal, 2011, 8, 1, 90

    CrossRef

  13. 13
    J Yun, K H Kim, E S Kang, G-Y Gwak, M S Choi, J E Lee, S J Nam, J-H Yang, Y H Park, J S Ahn, Y-H Im, Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy, British Journal of Cancer, 2011, 104, 4, 559

    CrossRef

  14. 14
    Tetsu Akimoto, Toshiya Otake, Akira Tanaka, Hideaki Takahashi, Toshihiko Higashizawa, Makoto Inoue, Katsuhiko Nishino, Osamu Saito, Norio Isoda, Shigeaki Muto, Kentaro Sugano, Eiji Kusano, Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases, Clinical and Experimental Nephrology, 2011, 15, 2, 289

    CrossRef

  15. 15
    Moonkyoo Kong, Seong Eon Hong, Byung-Ho Kim, Jinhyun Choi, Three Cases of Radiation-Induced Hepatitis B Virus Reactivation after Hepatic Tomotherapy: Case Report, The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2011, 29, 1, 53

    CrossRef

  16. 16
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  17. 17
    MARGARET JAMES KOZIEL, CHLOE LYNNE THIO, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  18. 18
    Winnie Yeo, Hepatitis B virus reactivation in association with antineoplastic therapy, Current Hepatitis Reports, 2009, 8, 3, 127

    CrossRef

  19. 19
    Tara N. Palmore, Neeral L. Shah, Rohit Loomba, Brian B. Borg, Uri Lopatin, Jordan J. Feld, Farooq Khokhar, Glen Lutchman, David E. Kleiner, Neal S. Young, Richard Childs, A. John Barrett, T. Jake Liang, Jay H. Hoofnagle, Theo Heller, Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression, Clinical Gastroenterology and Hepatology, 2009, 7, 10, 1130

    CrossRef

  20. 20
    Anthony Post, Shweta Nagendra, Reactivation of hepatitis B: Pathogenesis and clinical implications, Current Infectious Disease Reports, 2009, 11, 2, 113

    CrossRef

  21. 21
    Kazuhiko Hayashi, Yoshiaki Katano, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Hidemi Goto, Successful cessation of lamivudine using interferon in a patient with chronic hepatitis B who received prophylactic lamivudine treatment during chemotherapy, Clinical Journal of Gastroenterology, 2009, 2, 3, 210

    CrossRef

  22. 22
    Yong Yuan, Uchenna Iloeje, Hong Li, Joel Hay, Guang B. Yao, Economic Implications of Entecavir Treatment in Suppressing Viral Replication in Chronic Hepatitis B (CHB) Patients in China from a Perspective of the Chinese Social Security Program, Value in Health, 2008, 11,
  23. 23
    George K. K. Lau, Hepatitis B reactivation after chemotherapy: two decades of clinical research, Hepatology International, 2008, 2, 2, 152

    CrossRef

  24. 24
    Timucin Cil, Abdullah Altintas, Semir Pasa, Kadim Bayan, Tuncer Ozekinci, Abdurrahman Isikdogan, Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy, Leukemia & Lymphoma, 2008, 49, 5, 939

    CrossRef

  25. 25
    L. H. Katz, A. Fraser, A. Gafter-Gvili, L. Leibovici, R. Tur-Kaspa, Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis, Journal of Viral Hepatitis, 2008, 15, 2
  26. 26
    Lenna A. Martyak, Ehsan Taqavi, Sammy Saab, Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis, Liver International, 2008, 28, 1
  27. 27
    Ali Amouri, Lassaad Chtourou, Leila Mnif, Nabi Tahri, Prise en charge de la réactivation virale B au cours d’un traitement chimiothérapique ou immunosuppresseur, La Presse Médicale, 2008, 37, 11, 1591

    CrossRef

  28. 28
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  29. 29
    Sammy Saab, Mamie H. Dong, Tom A. Joseph, Myron J. Tong, Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model, Hepatology, 2007, 46, 4
  30. 30
    Jay H. Hoofnagle, Edward Doo, T. Jake Liang, Russell Fleischer, Anna S.F. Lok, Management of hepatitis B: Summary of a clinical research workshop, Hepatology, 2007, 45, 4
  31. 31
    Seong Man Kim, Ki Sung Lee, Chi Jun Park, Ja Young Lee, Kyung Ho Kim, Joon Yong Park, Jin Heon Lee, Hak Yang Kim, Jae Young Yoo, Myoung Kuk Jang, Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea, Journal of Infection, 2007, 54, 2, 185

    CrossRef

  32. 32
    Gadi Lalazar, Deborah Rund, Daniel Shouval, Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies, British Journal of Haematology, 2007, 136, 5
  33. 33
    Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, U Im Chang, Chang Wook Kim, Se Hyun Cho, Jun Yeol Han, Young Sok Lee, A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization, Hepatology, 2006, 43, 2
  34. 34
    Winnie Yeo, Philip J. Johnson, Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy, Hepatology, 2006, 43, 2
  35. 35
    Mark E. Mailliard, John L. Gollan, Emerging Therapeutics for Chronic Hepatitis B, Annual Review of Medicine, 2006, 57, 1, 155

    CrossRef

  36. 36
    Annarosa Floreani, Sara Boninsegna, Salvatore Lobello, Diego Caroli, Stefano Fagiuoli, Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal, Gastroentérologie Clinique et Biologique, 2006, 30, 2, 307

    CrossRef

  37. 37
    K. Ikeda, Y. Shiga, A. Takahashi, T. Kai, H. Kimura, K. Takeyama, H. Noji, K. Ogawa, A. Nakamura, H. Ohira, Y. Sato, Y. Maruyama, Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment, Leukemia & Lymphoma, 2006, 47, 1, 155

    CrossRef

  38. 38
    Debbie M Nathan, Peter W Angus, Peter R Gibson, Hepatitis B and C virus infections and anti-tumor necrosis factor-α therapy: Guidelines for clinical approach, Journal of Gastroenterology and Hepatology, 2006, 21, 9
  39. 39
    Bertrand Coiffier, Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine Prophylaxis, Cancer Investigation, 2006, 24, 5, 548

    CrossRef

  40. 40
    G. Perceau, N. Diris, O. Estines, C. Derancourt, S. Lévy, P. Bernard, Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma, British Journal of Dermatology, 2006, 155, 5
  41. 41
    H. E. KOHRT, D. L. OUYANG, E. B. KEEFFE, Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection, Alimentary Pharmacology & Therapeutics, 2006, 24, 7
  42. 42
    Hiroaki NUNOI, Yoshio TOKUMOTO, Yoshiyasu KISAKA, Shinya FURUKAWA, Yoichi HIASA, Hisaka MINAMI, Kojiro MICHITAKA, Norio HORIIKE, Morikazu ONJI, A case of autoimmune hepatitis with hepatitis B carrier was safely performed corticosteroid therapy by prophylaxis of lamivudine, Kanzo, 2005, 46, 9, 557

    CrossRef

  43. 43
    Marc Bourlière, Portage inactif du virus de l’hépatite B, Gastroentérologie Clinique et Biologique, 2005, 29, 4, 369

    CrossRef

  44. 44
    Themistoklis Vassiliadis, Vassilia Garipidou, Konstantinos Tziomalos, Vassilios Perifanis, Olga Giouleme, Sofia Vakalopoulou, Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series, American Journal of Hematology, 2005, 80, 3
  45. 45
    Joong-Won Park, Kyung Woo Park, Sang Hyung Cho, Hong Suk Park, Woo Jin Lee, Do Hoon Lee, Chang-Min Kim, Risk of Hepatitis B Exacerbation is Low After Transcatheter Arterial Chemoembolization Therapy for Patients with HBV-related Hepatocellular Carcinoma: Report of a Prospective Study, The American Journal of Gastroenterology, 2005, 100, 10, 2194

    CrossRef

  46. 46
    Emma C Thomson, Janice Main, Advances in hepatitis B and C, Current Opinion in Infectious Diseases, 2004, 17, 5, 449

    CrossRef

  47. 47
    Lior H Katz, Abigail Fraser, Leonard Leibovici, Rani Tur-Kaspa, Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy, The Cochrane Library,
  48. 48
    Lior H Katz, Abigail Fraser, Leonard Leibovici, Rani Tur-Kaspa, Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy, The Cochrane Library,